Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Merck reorganizes; Blackstone to fund trials for J&J drug

Summary by endpoints.news
Plus, news about Bristol Myers Squibb's Reblozyl: 🔀 A revamp at Merck: The New Jersey pharma giant announced on Monday that it’s splitting its human health organization in two ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

endpoints.newsendpoints.news

Merck reorganizes; Blackstone to fund trials for J&J drug

Plus, news about Bristol Myers Squibb's Reblozyl: 🔀 A revamp at Merck: The New Jersey pharma giant announced on Monday that it’s splitting its human health organization in two ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news on Monday, February 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Johnson & Johnson icon

Johnson & Johnson

New Jersey icon

New Jersey

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal